Skip to main content
OpenTrials
Not Yet Recruiting

NCT Number: NCT06830135

Telehealth Approach to Enhancing Glycemic Control

This study evaluates whether the use of a Continuous Glucose Monitoring (CGM) device combined with a Remote Patient Monitoring (RPM) program can improve blood sugar control and reduce hospital visits among patients with poorly controlled diabetes who have recently been discharged from the hospital.

The study, led by White Plains Hospital (WPH) Cares, will follow 208 patients for 90 days after their discharge. Half of the participants will receive standard care, while the other half will receive a Dexcom G7 CGM device along with support from trained nurses who will monitor their glucose readings daily. The goal is to determine whether this approach helps lower Hemoglobin A1c (HbA1c) levels, reduces hospital readmissions, and improves overall health outcomes.

Not Yet Recruiting

Trial opening soon.

Get Notified

Key information

Conditions

Diabetes Mellitus Endocrine System Diseases Glucose Metabolism Disorders Metabolic Diseases Nutritional and Metabolic Diseases

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Discharged Home from the WPH Inpatient Setting A1c >= 8.0 within 90 days of discharge >= 18 Years of Age Lives within Westchester County

Exclusion criteria

  • <18 Years of Age Patient With Documented Cognitive Impairment or Decisional Incapacity Pregnant or Plans to Become Pregnant in 6 Months Discharge Disposition of Short-term or Long-term Care Facility, Assisted Living Facility, Group Home, Against Medical Advice/Eloped, or Home Hospice Patient or Caregiver Unable to Check Glucose at Home Using a Home Glucometer Lives Outside Westchester County

Treatment and study plan

Continues glucose monitoring with remote glucose monitoring for 90 days

Device

CGM + RPM

Primary outcomes

  1. Hemoglobin A1c

    Time frame: 90 days

Secondary outcomes

  1. 30 days hospital readmissions

    Time frame: 30 days

  2. Overall healthcare utilization

    Time frame: 90 days

  3. Acute care visits related to abnormal glucose reading

    Time frame: 30 days

Other outcomes

  1. Percentage of Patients Enrolled in the Program

    Time frame: 2 years

  2. Changes in Medical Glucose Readings

    Time frame: 7 day

  3. Equity in Program Participation

    Time frame: 2 years

    (% of Participants Who Are Hispanic, African American, or Uninsured)

Study contacts

Contact information is provided by the study sponsor or research team.

Katarzyna Zarychta, MS

CONTACT

[email protected]

914-849-7429

Michelle Elsener, MBA, BSN, RN-BC, CPHQ

CONTACT

[email protected]

914-849-2273

Sponsors and collaborators

Lead sponsor

White Plains Hospital

Other

Registry information

Official study title

A Multifaceted Telehealth Approach to Enhancing Glycemic Control and Reducing Readmissions in a Diverse Diabetic Population: A Randomized Control Trial

Important dates

Study start
2025
Primary completion
2027
Study completion
2027
First posted
Feb 17, 2025
Registry last updated
Feb 17, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.